Intravascular device administration sets: Replacement after Standard Versus Prolonged use (The RSVP Trial)

血管内装置给药装置：标准使用后更换与长期使用（RSVP 试验）

• 批准号: nhmrc : 1008428
• 负责人: A/Pr E Geoffrey Playford
• 金额: $ 107.44万
• 依托单位: Griffith University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/intravascular-device-administration-rsvp-trial/109312
• 关键词: Intravascular; device; administration; sets; Replacement

Most hospital patients need an IV drip, a small plastic tube in a vein, often the hand/arm. 14 million/yr are used in Australia. IV drips are connected to plastic tubing through which fluid & medicine is given. IV tubing is needed for a week or more, but is only used for 3-4 days as it was thought this might prevent infection. It is now thought that IV tubing can be used for a week. This would save $1 billion/year & reduce nurses workload. The research will test the safety of this approach.

大多数住院患者需要静脉滴注，即在静脉中插入一根小塑料管，通常是手/手臂。澳大利亚每年使用 1,400 万个。静脉滴注器连接到塑料管，通过该管提供液体和药物。静脉输液管需要一周或更长时间，但仅使用 3-4 天，因为人们认为这可以预防感染。现在认为静脉输液管可以使用一周。这将每年节省 10 亿美元并减少护士的工作量。该研究将测试这种方法的安全性。